Annual Gross Profit
N/A
December 1, 2023
Summary
- CATX annual gross profit is not available.
Performance
CATX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Gross Profit
N/A
September 1, 2024
Summary
- CATX quarterly gross profit is not available.
Performance
CATX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Gross Profit
N/A
September 1, 2024
Summary
- CATX TTM gross profit is not available.
Performance
CATX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
CATX Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CATX Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Perspective Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $817.00 K(-82.3%) | - | - |
| Sep 2022 | - | $414.00 K(-55.3%) | $4.00 M(-13.3%) |
| Jun 2022 | - | $926.00 K(-35.7%) | $4.62 M(-8.3%) |
| Jun 2022 | $4.62 M(-9.9%) | - | - |
| Mar 2022 | - | $1.44 M(+18.1%) | $5.04 M(+1.6%) |
| Dec 2021 | - | $1.22 M(+18.6%) | $4.96 M(+1.1%) |
| Sep 2021 | - | $1.03 M(-23.6%) | $4.90 M(-4.2%) |
| Jun 2021 | $5.12 M(-0.1%) | - | - |
| Jun 2021 | - | $1.35 M(-1.2%) | $5.12 M(+5.7%) |
| Mar 2021 | - | $1.36 M(+16.7%) | $4.85 M(-6.6%) |
| Dec 2020 | - | $1.17 M(-6.3%) | $5.19 M(+1.1%) |
| Sep 2020 | - | $1.25 M(+16.3%) | $5.13 M(+0.2%) |
| Jun 2020 | $5.12 M(+68.2%) | $1.07 M(-37.2%) | $5.12 M(+3.9%) |
| Mar 2020 | - | $1.71 M(+53.6%) | $4.93 M(+20.1%) |
| Dec 2019 | - | $1.11 M(-10.1%) | $4.11 M(+9.2%) |
| Sep 2019 | - | $1.24 M(+40.6%) | $3.76 M(+23.4%) |
| Jun 2019 | $3.05 M(+65.4%) | $879.00 K(0.0%) | $3.05 M(+17.0%) |
| Mar 2019 | - | $879.00 K(+14.9%) | $2.60 M(+11.6%) |
| Dec 2018 | - | $765.00 K(+46.0%) | $2.33 M(+11.1%) |
| Sep 2018 | - | $524.00 K(+19.9%) | $2.10 M(+14.1%) |
| Jun 2018 | $1.84 M(+119.8%) | $437.00 K(-28.2%) | $1.84 M(-3.2%) |
| Mar 2018 | - | $609.00 K(+14.7%) | $1.90 M(+19.9%) |
| Dec 2017 | - | $531.00 K(+100.4%) | $1.59 M(+50.4%) |
| Sep 2017 | - | $265.00 K(-46.8%) | $1.05 M(+25.9%) |
| Jun 2017 | $838.00 K(+549.6%) | $498.00 K(+70.0%) | $838.00 K(+187.0%) |
| Mar 2017 | - | $293.00 K(<-9900.0%) | $292.00 K(+342.4%) |
| Dec 2016 | - | -$1000.00(-102.1%) | $66.00 K(-29.8%) |
| Sep 2016 | - | $48.00 K(-200.0%) | $94.00 K(-27.1%) |
| Jun 2016 | $129.00 K(-22.8%) | -$48.00 K(-171.6%) | $129.00 K(-66.2%) |
| Mar 2016 | - | $67.00 K(+148.1%) | $381.60 K(+3.2%) |
| Dec 2015 | - | $27.00 K(-67.5%) | $369.80 K(+21.3%) |
| Sep 2015 | - | $83.00 K(-59.4%) | $304.80 K(+82.5%) |
| Jun 2015 | $167.00 K(-185.0%) | $204.60 K(+270.7%) | $167.00 K(-196.1%) |
| Mar 2015 | - | $55.20 K(-245.3%) | -$173.80 K(-2.4%) |
| Dec 2014 | - | -$38.00 K(-30.7%) | -$178.10 K(+2.4%) |
| Sep 2014 | - | -$54.80 K(-59.8%) | -$174.00 K(-11.5%) |
| Jun 2014 | -$196.50 K | -$136.20 K(-367.6%) | -$196.50 K(-336.7%) |
| Mar 2014 | - | $50.90 K(-250.1%) | $83.00 K(-61.9%) |
| Dec 2013 | - | -$33.90 K(-56.1%) | $218.00 K(+133.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$77.30 K(-153.9%) | $93.30 K(-37.9%) |
| Jun 2013 | $150.20 K(-78.6%) | $143.30 K(-22.9%) | $150.20 K(-37.6%) |
| Mar 2013 | - | $185.90 K(-217.2%) | $240.60 K(-7.1%) |
| Dec 2012 | - | -$158.60 K(+677.5%) | $258.90 K(-58.0%) |
| Sep 2012 | - | -$20.40 K(-108.7%) | $616.40 K(-12.3%) |
| Jun 2012 | $703.20 K(-39.2%) | $233.70 K(+14.4%) | $703.10 K(-24.1%) |
| Mar 2012 | - | $204.20 K(+2.7%) | $925.90 K(-14.2%) |
| Dec 2011 | - | $198.90 K(+200.0%) | $1.08 M(+7.0%) |
| Sep 2011 | - | $66.30 K(-85.5%) | $1.01 M(-12.9%) |
| Jun 2011 | $1.16 M(+59.5%) | $456.50 K(+27.7%) | $1.16 M(+30.5%) |
| Mar 2011 | - | $357.40 K(+179.4%) | $887.10 K(+52.4%) |
| Dec 2010 | - | $127.90 K(-40.7%) | $582.20 K(-19.4%) |
| Sep 2010 | - | $215.60 K(+15.8%) | $722.50 K(-0.5%) |
| Jun 2010 | $725.80 K(-305.4%) | $186.20 K(+254.7%) | $725.90 K(+45.9%) |
| Mar 2010 | - | $52.50 K(-80.4%) | $497.50 K(+8.1%) |
| Dec 2009 | - | $268.20 K(+22.5%) | $460.20 K(-323.9%) |
| Sep 2009 | - | $219.00 K(-619.0%) | -$205.50 K(-41.9%) |
| Jun 2009 | -$353.30 K(+133.4%) | -$42.20 K(-377.6%) | -$353.40 K(-605.6%) |
| Mar 2009 | - | $15.20 K(-103.8%) | $69.90 K(-55.0%) |
| Dec 2008 | - | -$397.50 K(-659.1%) | $155.40 K(+123.9%) |
| Sep 2008 | - | $71.10 K(-81.3%) | $69.40 K(-145.8%) |
| Jun 2008 | -$151.40 K(+177.3%) | $381.10 K(+278.5%) | -$151.50 K(-71.9%) |
| Mar 2008 | - | $100.70 K(-120.8%) | -$540.00 K(+19.5%) |
| Dec 2007 | - | -$483.50 K(+222.8%) | -$452.00 K(-875.3%) |
| Sep 2007 | - | -$149.80 K(+1924.3%) | $58.30 K(-206.8%) |
| Jun 2007 | -$54.60 K(-97.0%) | -$7400.00(-103.9%) | -$54.60 K(-91.1%) |
| Mar 2007 | - | $188.70 K(+604.1%) | -$616.50 K(-44.8%) |
| Dec 2006 | - | $26.80 K(-110.2%) | -$1.12 M(-29.0%) |
| Sep 2006 | - | -$262.70 K(-53.9%) | -$1.57 M(-13.5%) |
| Jun 2006 | -$1.82 M(<-9900.0%) | -$569.30 K(+82.4%) | -$1.82 M(+45.5%) |
| Mar 2006 | - | -$312.20 K(-27.4%) | -$1.25 M(+33.2%) |
| Dec 2005 | - | -$430.00 K(-15.6%) | -$939.30 K(+84.4%) |
| Sep 2005 | - | -$509.30 K(<-9900.0%) | -$509.30 K(<-9900.0%) |
| Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | - | - |
| Mar 2004 | - | $0.00 | $0.00 |
| Sep 1997 | $0.00(-100.0%) | - | - |
| Sep 1996 | $795.60 K(-3.2%) | - | - |
| Sep 1995 | $822.30 K(+123.5%) | - | - |
| Sep 1994 | $367.90 K | - | - |
FAQ
- What is the all time high annual gross profit for Perspective Therapeutics?
- What is the all time high quarterly gross profit for Perspective Therapeutics?
- What is the all time high TTM gross profit for Perspective Therapeutics?
What is the all time high annual gross profit for Perspective Therapeutics?
Perspective Therapeutics all-time high annual gross profit is $5.12 M
What is the all time high quarterly gross profit for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly gross profit is $1.71 M
What is the all time high TTM gross profit for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM gross profit is $5.19 M